Upload Avatar (500 x 500)
Xiaoyuan Chu
Medical School
Nanjing University
Jiangsu
Language: Chinese, English
Cancer
Tumor
Immunotherapy
Metastasis
Drug Resistance
Gastrointestinal Tumors
Respiratory Tumors
Clinical Diagnosis
Treatment
Research
Areas of Focus
- Oncology
Academic Background & Achievements
- 1992 - Bachelor's Degree: Second Military Medical University
- 1999 - Master's Degree: First Military Medical University
- 2007 - Doctorate: Second Military Medical University
- 2012 - Visiting Scholar: University of Massachusetts Medical School
Publications
- MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop, Chen Yanyan, Wang Bin, Huang Mengxi, Wang Tao, Hu Chao, Liu Qin, Han Dong, Chen Cheng, Zhang Junliang, Li Zhiping, Liu Chao, Lei Wenbin, Chang Yue, Wu Meijuan, Xiang Dan, Chen Yitian, Wang Rui, Huang Weiqian, Lei Zengjie, Chu Xiaoyuan, 2020
- PHF5A promotes colorectal cancer progression by alternative splicing of TEAD2, Chang Y, Zhao Y, Wang L, Wu M, He C, Huang M, Lei Z, Yang J, Han S, Wang B, Chen Y, Liu C, Yu H, Xue L, Geng J, Chen Y, Dai T, Ren L, Wang Q, Liu X, Chu X, Chen C, 2021
- Lysine methylation of transcription factors in cancer, Han D, Huang M, Wang T, Li Z, Chen Y, Liu C, Lei Z, Chu X, 2019
- Dysregulation of miR-6868-5p/FOXM1 circuit contributes to colorectal cancer angiogenesis, Ye Wang, Meijuan Wu, Zengjie Lei, Mengxi Huang, Zhiping Li, Liya Wang, Qijun Cao, Dong Han, Yue Chang, Yanyan Chen, Xiaobei Liu, Lijun Xue, Xiaobei Mao, Jian Geng, Yanan Chen, Tingting Dai, Lili Ren, Qian Wang, Hongju Yu, Cheng Chen, Xiaoyuan Chu, 2018
- New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications, Ye Wang, Liya Wang, Cheng Chen, Xiaoyuan Chu, 2018
- Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma, Mengxi Huang, Cheng Chen, Jian Geng, Dong Han, Tao Wang, Tao Xie, Liya Wang, Ye Wang, Chun hua Wang, Zengjie Lei, Xiaoyuan Chu, 2017
Awards
- Military Medical Achievement Second Prize (2013): Research on molecular targets and resistance intervention strategies for personalized treatment of lung adenocarcinoma
- Military Science and Technology Progress Third Prize (2016): Research on the mechanism and prevention of epigenetic changes in the genome triggered by low-dose radiation
